GH Secretagogue Peptide
CJC-1295 (No DAC)
GHRH(1-29) analog without the drug affinity complex, studied in pulsatile GH release models.
$79.00
Free shipping on orders over $300 · Same-day dispatch before 2PM EST
Volume Discounts
Don't forget your reconstitution solution
Bacteriostatic Water 30mL
$25.00
Purchase Options
Lab Verified
HPLC-MS + endotoxin
Same-Day Ship
Orders by 2PM EST
Damage Coverage
Free replacement
Discreet Packaging
Plain outer box
Research Use Only
Not for human or veterinary consumption. For laboratory and in-vitro research purposes only.
Total
$79.00
Description
CJC-1295 (No DAC) is a 29-amino-acid GHRH analog (Modified GRF 1-29) studied for its activity at the GHRH receptor without the extended half-life imparted by DAC conjugation.
Supplied as a sterile lyophilized powder for reconstitution. For laboratory research use only.
Each batch is independently verified by HPLC-MS before release.
Reconstitution
Reconstitute with bacteriostatic water in your preferred ratio. Store reconstituted vials refrigerated (2–8 °C) and use within recommended timeframes for your protocol.
Storage
Unreconstituted lyophilized powder stable at room temperature for short periods; refrigerate (2–8 °C) for long-term storage. Avoid repeat freeze/thaw cycles.
- Dose
- 10mg
- Purity
- ≥ 99%
- Form
- Lyophilized powder
- Storage
- Refrigerate after reconstitution
- Origin
- USA — synthesized & shipped domestically
- Testing
- HPLC-MS, MALDI, endotoxin screen
Certificate of analysis available on request
The batch certificate for this item isn't published online yet. Request it here and we'll email you the lab report for the batch you receive.
Research Overview
CJC-1295 (No DAC) — also known as Modified GRF 1-29 — is a 29-amino-acid analog of growth hormone–releasing hormone (GHRH) lacking the Drug Affinity Complex. Without albumin binding, it retains a short, physiologically pulsatile profile in research models.
It is widely used in somatotropic research to study acute GHRH receptor activation and pulsatile GH release patterns, often in combination with ghrelin-receptor agonists such as ipamorelin.
Mechanism of Action
Activates the GHRH receptor on pituitary somatotrophs, stimulating pulsatile GH release in laboratory models without the prolonged baseline elevation produced by DAC-conjugated analogs.
Research Applications
- Pulsatile GH-axis research
- GHRH receptor pharmacology
- Secretagogue synergy studies (e.g., with ipamorelin)
Reconstitution & Handling
Certificate of Analysis
Lot / Batch
QP-2025-3679
- Product
- CJC-1295 (No DAC)
- Manufacture date
- 2025-04-20
- Test date
- 2025-04-23
- Expiration
- 2028-04-20
- Appearance
- White to off-white lyophilized powder
- Identity
- Confirmed — matches reference standard
- Purity (HPLC)
- 99.70%
- Water content (KF)
- 1.90%
- Endotoxin (LAL)
- < 0.09 EU/mg
- Bioburden
- < 1 CFU / vial
- Analytical methods
- RP-HPLC, ESI-MS, MALDI-TOF, LAL endotoxin assay
- Released by
- QPUSA Quality Assurance Lab
Related products
